Document is current

Article History

Received: 13 July 2020

Accepted: 21 January 2021

First Online: 30 January 2021

Declarations

:

: None of the funding sources participated in the execution of the project, generation of results, interpretation of the data, nor drafting of the manuscript.

: PS reports receiving grants and/or salary and/or research support from the Centre for Addiction and Mental Health; Health Canada; Ontario Ministry of Health and Long-term care; Canadian Institutes of Health Research; Canadian Centre on Substance Use and Addiction; Public Health Agency of Canada; Ontario Lung Association; Medical Psychiatry Alliance; Extensions for Community Healthcare Outcomes; Canadian Cancer Society Research Institute; Cancer Care Ontario; Ontario Institute for Cancer Research; Ontario Brain Institute; McLaughlin Centre; Academic Health Sciences Centre; Workplace Safety and Insurance Board; National Institutes of Health; and the Association of Faculties of Medicine of Canada. PS also reports receiving funding and/or honoraria from the following commercial organizations: Pfizer Inc./Canada, Shoppers Drug Mart, Bhasin Consulting Fund Inc., Patient-Centered Outcomes Research Institute, ABBVie, and Bristol-Myers Squibb. Further, PS reports receiving consulting fees from Pfizer Inc./Canada, Evidera Inc., Johnson & Johnson Group of Companies, Medcan Clinic, Inflexxion Inc., V-CC Systems Inc., MedPlan Communications, Kataka Medical Communications, Miller Medical Communications, Nvision Insight Group, and Sun Life Financial. LZ has received peer-reviewed funding from Canadian Institutes of Health Research, Canadian Cancer Society, and Ontario Ministry of Health of Long-term Care, including salary support from Pfizer Inc. (GRAND Award) and the Health Services Research Fund from the Ontario Ministry of Health. All other authors declare no conflict of interest.